Primate models of movement disorders of basal ganglia origin
- 1 July 1990
- journal article
- review article
- Published by Elsevier in Trends in Neurosciences
- Vol. 13 (7) , 281-285
- https://doi.org/10.1016/0166-2236(90)90110-v
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- The functional anatomy of basal ganglia disordersTrends in Neurosciences, 1989
- Changes in local cerebral glucose utilization associated with Parkinson's syndrome induced by 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) in the primateLife Sciences, 1987
- Locus ceruleus lesions and eosinophilic inclusions in MPTP‐treated monkeysAnnals of Neurology, 1986
- Hemiparkinsonism in monkeys after unilateral internal carotid artery artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)Life Sciences, 1986
- Parallel Organization of Functionally Segregated Circuits Linking Basal Ganglia and CortexAnnual Review of Neuroscience, 1986
- Neural mechanisms mediating 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the monkey: Relative contributions of the striatopallidal and striatonigral pathways as suggested by 2-deoxyglucose uptakeNeuroscience Letters, 1986
- Changes in the local cerebral metabolic rate for glucose in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) primate model of Parkinson's diseaseBrain Research, 1985
- Sites of the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the macaque monkey include the ventral tegmental area and the locus coeruleusNeuroscience Letters, 1985
- Regional brain uptake of 2-deoxyglucose in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)—induced parkinsonism in the macaque monkeyNeuropharmacology, 1985
- Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkeyBrain Research, 1984